human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Product
RxNorm concept 1161537, clinical dose form group (scdg).
- RxCUI
- 1161537
- Term type
- Clinical dose form group (SCDG)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1161537 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- human-bovine reassortant rotavirus strain G1 vaccine (IN, has ingredient)
- human-bovine reassortant rotavirus strain G2 vaccine (IN, has ingredient)
- human-bovine reassortant rotavirus strain G3 vaccine (IN, has ingredient)
- human-bovine reassortant rotavirus strain G4 vaccine (IN, has ingredient)
- human-bovine reassortant rotavirus strain P1A[8] vaccine (IN, has ingredient)
- RotaTeq Oral Product (SBDG, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1161537 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1161537 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1161537. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.